digital money scales, Knowledge

The restricted shares with a market value of 644 million yuan were lifted today. Xishan Technology, Betray and Wanda Bearing were among the top companies in terms of market value. On Friday (December 13th), the restricted shares of eight companies were lifted, with a total lifting amount of 20,925,400 shares. According to the latest closing price, the total lifting market value was 644 million yuan. Judging from the amount of lifting the ban, Betray, Xishan Technology and Nanwang Technology were among the top, with 9,834,300 shares, 3,706,800 shares and 3,247,500 shares respectively. Judging from the market value of lifting the ban, the number of shares lifted by 0 companies exceeded 100 million yuan. Xishan Technology, Betray and Wanda Bearing are among the top companies in terms of market value, with market values of 246 million yuan, 229 million yuan and 76.73 million yuan respectively. From the perspective of the proportion of shares released from the ban to the total share capital, Xishan Technology, Wanda Bearing and Nanwang Technology are among the top, with 7.47%, 3.08% and 1.66% respectively.Luxury car dealers "switch to" domestic brands, and the competition between new and old forces spread to the channel side. Recently, Beijing Huayang Aotong Automobile Sales Co., Ltd. (referred to as "Huayang Aotong") announced that "the company will no longer continue the distribution business of Audi brands, but will continue to engage in the maintenance business of Audi models". On December 12, the reporter went to Huayang Aotong in Laiguangying, Beijing. The above announcement was posted at the entrance, and the store has been replaced with the "AITO" logo. There is no Audi car in the store, and it has been replaced by two models for sale in the world. A luxury brand dealer who did not want to be named revealed to reporters that Huayang Aotong had indeed been cancelled by Audi, and Zhengzhou Zhongsheng Huidi Store was also withdrawn from the network with it, all because it switched to Huawei's channel network without permission. "The war between new forces and traditional car companies has burned from the product side to the channel side." According to Zhang Xiuyang, secretary-general of China Passenger Car Industry Alliance, the "price war" that lasted for nearly two years has made it difficult for car dealers who are in retail terminals and have been upside down all the year round, and their loyalty has also declined. At the same time, in the tide of the era of smart cars, the concept of consumption is changing rapidly, and the high-end electric vehicle brands in China are gradually winning the wide favor of the market and consumers. (Securities Daily)The troops stationed in Macao are the anchor of maintaining prosperity and stability. This year marks the 25th anniversary of Macao's return to the motherland. Senior Colonel Wu Qian, director of the Information Bureau of the Ministry of National Defense and spokesman of the Ministry of National Defense, said today that the troops stationed in Macao are an important manifestation of national sovereignty. In the past 25 years, especially since the 18th National Congress of the Communist Party of China, the troops stationed in Macao have resolutely implemented the policy of "one country, two systems", conscientiously implemented the Basic Law and the Garrison Law, comprehensively strengthened army building, successfully fulfilled various tasks centered on defense, and effectively safeguarded national sovereignty, security and Macao's prosperity and stability. Looking forward to the future, the troops stationed in Macao will always be loyal guardians assured by the Party and the people, the powerful force of Haojiang trusted by Macao compatriots, and the "anchor needle" for maintaining Macao's prosperity and stability. (CCTV military)

Compared with the beginning of the personal pension system, the number of participating insurance companies has increased nearly four times, and insurance companies have become an important supplier of personal pension products. The comprehensive opening of the personal pension system will undoubtedly create a historical opportunity for the insurance industry to participate more deeply in the construction of the third pillar. (SSE)"Shanghai housing subsidy is 300,000 yuan" and "down payment is 20,000 yuan to buy 1.8 million hardcover existing houses"? Rumor has come. Recently, there have been a number of housing advertisements on the short video platform. The agent who released the housing claimed that he could receive the "housing subsidy" when buying a house in Shanghai, with the amount ranging from 200,000 yuan to 300,000 yuan. An intermediary declared: "Shanghai Songjiang New Town has a total price of 760,000 yuan and a housing subsidy of 250,000 yuan." "After receiving the subsidy, you can buy a 78-square-meter house with a down payment of 50,000 yuan." There is also an intermediary who claims: "The minimum payment can be only 20,000 yuan, and you can buy a finely decorated existing house with a total price of 1.8 million yuan." The reporter consulted a number of intermediaries and learned that the so-called "purchase subsidies" appearing in short videos are not government subsidies, but gimmicks. When the house-watchers consult subsidies on the spot, different intermediaries will have different calibers. Usually, there are three routines-one is to raise the price first and then lower the price. Second, the so-called "subsidy" is actually that developers lend money to buyers to pay down payment, and buyers have to pay interest. Third, the commission returned by the intermediary to the buyers is packaged as a "subsidy". (Shanghai rumor platform)Onlikon: Compound α-keto acid tablets are planned to be selected for the tenth batch of national centralized drug procurement. Onlikon announced on December 13, and on December 12, the company participated in the bidding for the tenth batch of national centralized drug procurement organized by the National Drug Joint Procurement Office. After the bid opening and evaluation by the Joint Procurement Office, the company plans to select this centralized drug procurement. The indication of that medicine is to prevent and treat the damage caused by metabolic disorder in protein due to chronic renal insufficiency. The drug is a national medical insurance catalogue product, with an annual sales of 218,900 yuan in 2023, accounting for 0.01% of the company's annual operating income in 2023.

Ministry of National Defense: Fujian Ship will gradually launch the follow-up test project. On the morning of December 13th, Senior Colonel Wu Qian, director of the Information Bureau of the Ministry of National Defense and spokesman of the Ministry of National Defense, released a message on the recent military-related issues. Reporter: According to the announcement of Shanghai Maritime Safety Administration, in early December, traffic control was implemented for the import of a large ship in the deep water channel of the Yangtze River estuary. Some analysts believe that China Navy Fujian Ship may have completed its fifth sea trial and returned to its home port. Can you confirm it? Wu Qian: It is a normal arrangement for Fujian Ship to carry out relevant tests during the construction process. In the next step, follow-up test projects will be gradually launched according to the progress of aircraft carrier construction. (issued by the Ministry of National Defense)Du Zhaocai, former deputy director of the State Sports General Administration, will be sentenced in the first instance today. Today, Du Zhaocai, former deputy director of the State Sports General Administration, will be sentenced in the Wuhan Intermediate People's Court.Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.